Volume 27, Issue 1

Search all International Journal of Clinical Oncology articles

January 2022

Including Invited Reviews on Cancer among adolescents and young adults in Japan – 1

Filter by

Volume:

Sort by

Date published:

New to old Old to new

29 articles in this issue

Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021)
Keisuke Matsusaki
Kuniaki Aridome
Joji Kitayama
Special Article Open access 20 November 2021 Pages: 1 - 6
Part of 1 collection:

Guidelines
Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy
Kayo Nakata
Eiso Hiyama
Isao Miyashiro
Invited Review Article Open access 15 November 2021 Pages: 7 - 15
Current status of AYA-generation breast cancer: trends worldwide and in Japan
Manabu Futamura
Kazuhiro Yoshida
Invited Review Article 18 December 2021 Pages: 16 - 24
Current state of fertility preservation for adolescent and young adult patients with gynecological cancer
Tatsuru Ohara
Shiho Kuji
Nao Suzuki
Invited Review Article 15 November 2021 Pages: 25 - 34
Critical appraisal of epigenetic regulation of galectins in cancer
Ashita Gadwal
Anupama Modi
Purvi Purohit
Review Article 15 October 2021 Pages: 35 - 44
Key promoters of tumor hallmarks
Keywan Mortezaee
Jamal Majidpoor
Review Article 13 November 2021 Pages: 45 - 58
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis
Takafumi Yanagisawa
Keiichiro Mori
Shahrokh F. Shariat
Review Article Open access 10 November 2021 Pages: 59 - 71
Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers
Tatsuki Nanami
Isamu Hoshino
Hideaki Shimada
Original Article 11 October 2021 Pages: 72 - 76
The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group
Kenichiro Asano
Yoji Yamashita
Teiji Tominaga
Original Article 12 October 2021 Pages: 77 - 94
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study
Ryuji Yasumatsu
Yasushi Shimizu
Akihiro Homma
Original Article Open access 13 November 2021 Pages: 95 - 104
Heterogeneous distribution of PD-L1 expression in the IASLC/ATS/ERS classification of lung adenocarcinoma
Dachuan Zhang
Xie Gao
Qing Li
Original Article 06 October 2021 Pages: 105 - 111
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)
Yukari Tsubata
Kana Watanabe
Takeshi Isobe
Original Article Open access 13 October 2021 Pages: 112 - 120
Large and diffuse ductal carcinoma in situ: potentially lethal subtypes of “preinvasive” disease
Thomas J. O’Keefe
Olivier Harismendy
Anne M. Wallace
Original Article 07 October 2021 Pages: 121 - 130
Preoperative transferrin level is a novel indicator of short- and long-term outcomes after esophageal cancer surgery
Taishi Yamane
Hiroshi Sawayama
Hideo Baba
Original Article 29 September 2021 Pages: 131 - 140
Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study
Shinya Abe
Kazushige Kawai
Soichiro Ishihara
Original Article 06 November 2021 Pages: 141 - 153
Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study
Satoshi Tamada
Chihiro Kondoh
Hirotsugu Uemura
Original Article Open access 20 November 2021 Pages: 154 - 164
Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis
Teruki Isobe
Taku Naiki
Takahiro Yasui
Original Article 11 October 2021 Pages: 165 - 174
Sarcopenia is associated with survival in patients with urothelial carcinoma treated with systemic chemotherapy
Ryutaro Shimizu
Masashi Honda
Atsushi Takenaka
Original Article 04 October 2021 Pages: 175 - 183
How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?
Fumihiko Urabe
Takahiro Kimura
Shin Egawa
Original Article 02 October 2021 Pages: 184 - 193
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study
Yoichiro Tohi
Takuma Kato
Mikio Sugimoto
Original Article 02 October 2021 Pages: 194 - 201
Comparison of treatment outcomes of pelvis external radiotherapy with and without vaginal brachytherapy for cervical cancer patients with positive or close vaginal resected margins
Yun Hee Lee
Yeon Sil Kim
Sung Hwan Kim
Original Article 22 October 2021 Pages: 202 - 212
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma
Koji Kato
Shinichi Makita
Kiyohiko Hatake
Original Article Open access 01 October 2021 Pages: 213 - 223
A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myeloma
Shinsuke Iida
Tohru Izumi
Makoto Sasaki
Original Article Open access 02 October 2021 Pages: 224 - 233
An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors
Akiyoshi Shimatani
Manabu Hoshi
Hiroaki Nakamura
Original Article 10 October 2021 Pages: 234 - 243
Correction to: An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors
Akiyoshi Shimatani
Manabu Hoshi
Hiroaki Nakamura
Correction 17 October 2021 Pages: 244 - 244
Changes of cancer diagnosis disclosure to children in Japan in the last 20 years
Hiroki Hori
Asuka Ohta
Kyoko Kobayashi
Original Article 01 October 2021 Pages: 245 - 252
Clinical impact of primary tumour ¹²³ImIBG response to induction chemotherapy in children with high-risk neuroblastoma
Elwira Szychot
Daniel Morgenstern
Lorenzo Biassoni
Original Article 09 October 2021 Pages: 253 - 261
Correction to: Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1
Tadashi Kumamoto
Fumito Yamazaki
Yukiko Tsunematsu
Correction Open access 03 December 2021 Pages: 262 - 263
Retraction Note to: Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma
Chuantao Zhang
Jianxiang Liu
Yufeng Xing
Retraction Note 13 November 2021 Pages: 264 - 264

Volume 27, Issue 1

Search

Navigation